| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $55.2M | +9.5% |
| Cost of Revenue | $27.0M | +11.1% |
| Gross Profit | $28.2M | +8.1% |
| R&D Expense | $14.1M | +2.9% |
| SG&A Expense | $14.6M | +2.9% |
| Operating Income | -$6.5M | +8.2% |
| Pre-tax Income | -$457K | -161.7% |
| Income Tax | $129K | +422.5% |
| Net Income | -$586K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.5M | +5.6% |
| Accounts Receivable | $8.1M | -30.9% |
| Inventory | $10.7M | +17.8% |
| Current Assets | $65.2M | +1.5% |
| Total Assets | $84.6M | +8.8% |
| Current Liabilities | $13.5M | +35.7% |
| Long-term Debt | $15K | -99.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.0M | +40.3% |
| Capital Expenditures | $6.8M | +124.3% |
| Investing Cash Flow | -$8.7M | -183.5% |
| Financing Cash Flow | $1.1M | -4.0% |
| Free Cash Flow | $3.1M | -22.9% |
| -175.0% |
| EPS (Basic) | -$0.03 | -175.0% |
| EPS (Diluted) | -$0.03 | -175.0% |
| Total Liabilities |
| $15.7M |
| +3.3% |
| Stockholders' Equity | $68.9M | +10.1% |